Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	4.41M -64.2%
Revenue (ttm)	n/a
Net Income	-3.14M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,246
Open	0.0595
Previous Close	0.0595
Day's Range	0.0595 - 0.0595
52-Week Range	0.0200 - 0.1890
Beta	n/a
RSI	55.03
Earnings Date	Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD